Roche launches Elecsys Anti-p53 immunoassay to aid diagnosis of various cancer types - Seite 3

[3] Soussi T. Cancer Res 2000;60:1777-88
[4] Kastenhuber E & Lowe S. Cell 2017;170(6):1062-78

Roche Group Media Relations
Phone: [phone] / e-mail: [e-mail]

Dr. Nicolas Dunant Phone: [phone]	Patrick Barth Phone: [phone]
Dr. Daniel Grotzky Phone: [phone]	Karsten Kleine Phone: [phone]
Nina Mählitz Phone: [phone]	Nathalie Meetz Phone: [phone]
Dr. Barbara von Schnurbein Phone: [phone]

Roche Investor Relations
Dr. Karl Mahler Phone: [phone] e-mail: [e-mail]	Jon Kaspar Bayard Phone: [phone] e-mail: [e-mail]
Dr. Sabine Borngräber Phone: [phone] e-mail: [e-mail]	Dr. Bruno Eschli Phone: [phone] e-mail: [e-mail]
Dr. Birgit Masjost Phone: [phone] e-mail: [e-mail]	Dr. Gerard Tobin Phone: [phone] e-mail: [e-mail]
Investor Relations North America
Loren Kalm Phone: [phone] e-mail: [e-mail]	Dr. Lisa Tuomi Phone: [phone] e-mail: [e-mail]

Attachment

• 07042021_MR_Elecsys Anti-p53_EN